Skip to main content
Top
Published in: BMC Infectious Diseases 1/2008

Open Access 01-12-2008 | Research article

Default from tuberculosis treatment in Tashkent, Uzbekistan; Who are these defaulters and why do they default?

Authors: Epco Hasker, Maksad Khodjikhanov, Shakhnoz Usarova, Umid Asamidinov, Umida Yuldashova, Marieke J van der Werf, Gulnoz Uzakova, Jaap Veen

Published in: BMC Infectious Diseases | Issue 1/2008

Login to get access

Abstract

Background

In Tashkent (Uzbekistan), TB treatment is provided in accordance with the DOTS strategy. Of 1087 pulmonary TB patients started on treatment in 2005, 228 (21%) defaulted. This study investigates who the defaulters in Tashkent are, when they default and why they default.

Methods

We reviewed the records of 126 defaulters (cases) and 132 controls and collected information on time of default, demographic factors, social factors, potential risk factors for default, characteristics of treatment and recorded reasons for default.

Results

Unemployment, being a pensioner, alcoholism and homelessness were associated with default. Patients defaulted mostly during the intensive phase, while they were hospitalized (61%), or just before they were to start the continuation phase (26%). Reasons for default listed in the records were various, 'Refusal of further treatment' (27%) and 'Violation of hospital rules' (18%) were most frequently recorded. One third of the recorded defaulters did not really default but continued treatment under 'non-DOTS' conditions.

Conclusion

Whereas patient factors such as unemployment, being a pensioner, alcoholism and homelessness play a role, there are also system factors that need to be addressed to reduce default. Such system factors include the obligatory admission in TB hospitals and the inadequately organized transition from hospitalized to ambulatory treatment.
Literature
1.
go back to reference WHO: Global tuberculosis control: surveillance, planning, financing. WHO report 2008. WHO/HTM/TB/2008.393, Annex 3. 2008, Geneva, WHO WHO: Global tuberculosis control: surveillance, planning, financing. WHO report 2008. WHO/HTM/TB/2008.393, Annex 3. 2008, Geneva, WHO
2.
go back to reference WHO: Anti-tuberculosis drug resistance in the world. Fourth Global Report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 2002–2007. WHO/HTM/TB/2008.394. 2008, Geneva, WHO WHO: Anti-tuberculosis drug resistance in the world. Fourth Global Report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 2002–2007. WHO/HTM/TB/2008.394. 2008, Geneva, WHO
4.
go back to reference WHO: Treatment of tuberculosis: guidelines for national programmes. WHO/CDS/TB/2003.1313. 2003, Geneva, WHO WHO: Treatment of tuberculosis: guidelines for national programmes. WHO/CDS/TB/2003.1313. 2003, Geneva, WHO
5.
go back to reference Kherosheva T, Thorpe LE, Kiryanova E, Rybka L, Gerasichev V, Shulgina M, Nemtsova E, Aptekar T, Kluge H, Jakubowiak W, Grzemska M, Aquino G, Wells C, Kazionny B: Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia. Int J Tuberc Lung Dis. 2003, 7: 1045-1051.PubMed Kherosheva T, Thorpe LE, Kiryanova E, Rybka L, Gerasichev V, Shulgina M, Nemtsova E, Aptekar T, Kluge H, Jakubowiak W, Grzemska M, Aquino G, Wells C, Kazionny B: Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia. Int J Tuberc Lung Dis. 2003, 7: 1045-1051.PubMed
6.
go back to reference Balabanova Y, Drobniewski F, Fedorin I, Zakharova S, Nikolayevskyy V, Atun R, Coker R: The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res. 2006, 7: 44-10.1186/1465-9921-7-44.CrossRefPubMedPubMedCentral Balabanova Y, Drobniewski F, Fedorin I, Zakharova S, Nikolayevskyy V, Atun R, Coker R: The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res. 2006, 7: 44-10.1186/1465-9921-7-44.CrossRefPubMedPubMedCentral
7.
go back to reference O'Boyl SJ, Power JJ, Ibrahim MY, Watson JP: Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis. 2002, 6: 307-312. O'Boyl SJ, Power JJ, Ibrahim MY, Watson JP: Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis. 2002, 6: 307-312.
8.
go back to reference Comolet TM, Rakotomalala R, Rajaonarioa H: Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis. 1998, 2 (11): 891-897.PubMed Comolet TM, Rakotomalala R, Rajaonarioa H: Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis. 1998, 2 (11): 891-897.PubMed
9.
go back to reference Carreira Teixeira Belo MT, Selig L, Raggio Luiz R, Hanson C, Luna AL, Guimarães Teixeira E, Trajman A: Choosing incentives to stimulate tuberculosis treatment compliance in a poor county in Rio de Janeiro state, Brazil. Med Sci Monit. 2006, 12: PH1-5. Carreira Teixeira Belo MT, Selig L, Raggio Luiz R, Hanson C, Luna AL, Guimarães Teixeira E, Trajman A: Choosing incentives to stimulate tuberculosis treatment compliance in a poor county in Rio de Janeiro state, Brazil. Med Sci Monit. 2006, 12: PH1-5.
10.
go back to reference Bam TS, Gunneberg C, Chamroonsawasdi K, Bam DS, Aalberg O, Kasland O, Shiyalap K, Srisorrachatr S: Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal. Int J Tuberc Lung Dis. 2006, 10: 270-276.PubMed Bam TS, Gunneberg C, Chamroonsawasdi K, Bam DS, Aalberg O, Kasland O, Shiyalap K, Srisorrachatr S: Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal. Int J Tuberc Lung Dis. 2006, 10: 270-276.PubMed
11.
go back to reference Liam CK, Lim KH, Wong M, Tang B: Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis. 1999, 3: 300-309.PubMed Liam CK, Lim KH, Wong M, Tang B: Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis. 1999, 3: 300-309.PubMed
12.
go back to reference Gelmanova IY, Keshavjee S, Golubchikova VT, Berezina VI, Strelis AK, Yanova GV, Atwood S, Murray M: Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ. 2007, 85: 703-711. 10.2471/BLT.06.038331.CrossRefPubMedPubMedCentral Gelmanova IY, Keshavjee S, Golubchikova VT, Berezina VI, Strelis AK, Yanova GV, Atwood S, Murray M: Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ. 2007, 85: 703-711. 10.2471/BLT.06.038331.CrossRefPubMedPubMedCentral
13.
go back to reference Fry RS, Khoshnood K, Vdovichenko E, Granskaya J, Sazhin V, Shpakovskaya L, Zhemkov V, Zhemkova M, Rowhani-Rahbar A, Funk M, Kozlov A: Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St Petersburg, Russia. Int J Tuberc Lung Dis. 2007, 9 (9): 1027-1033. Fry RS, Khoshnood K, Vdovichenko E, Granskaya J, Sazhin V, Shpakovskaya L, Zhemkov V, Zhemkova M, Rowhani-Rahbar A, Funk M, Kozlov A: Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St Petersburg, Russia. Int J Tuberc Lung Dis. 2007, 9 (9): 1027-1033.
14.
go back to reference Jakubowiak WM, Bogorodskaya EM, Borisov ES, Danilova DI, Kourbatova EK: Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis. 2007, 11: 46-53.PubMed Jakubowiak WM, Bogorodskaya EM, Borisov ES, Danilova DI, Kourbatova EK: Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis. 2007, 11: 46-53.PubMed
15.
go back to reference Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS: Treating Multidrug-Resistant Tuberculosis in Tomsk, Russia: Developing Programs That Address the Linkage between Poverty and Disease. Ann NY Acad Sci. 2008, 1-11. 10.1196/annals.1425.009. Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS: Treating Multidrug-Resistant Tuberculosis in Tomsk, Russia: Developing Programs That Address the Linkage between Poverty and Disease. Ann NY Acad Sci. 2008, 1-11. 10.1196/annals.1425.009.
16.
go back to reference Hasker E, Khodjikahanov M, Uzarova S, Yuldasheva U, Uzakova G, Veen J: Health care seeking behaviour for TB symptoms in two provinces of Uzbekistan. Trop Doct. 2008, 38: 107-109. 10.1258/td.2007.070003.CrossRefPubMed Hasker E, Khodjikahanov M, Uzarova S, Yuldasheva U, Uzakova G, Veen J: Health care seeking behaviour for TB symptoms in two provinces of Uzbekistan. Trop Doct. 2008, 38: 107-109. 10.1258/td.2007.070003.CrossRefPubMed
17.
go back to reference Kruk ME, Schwalbe NR, Aguiar CA: Timing of default from tuberculosis treatment: a systematic review. Trop Med Int Health. 2008, 13: 1-10. Kruk ME, Schwalbe NR, Aguiar CA: Timing of default from tuberculosis treatment: a systematic review. Trop Med Int Health. 2008, 13: 1-10.
18.
go back to reference Mitcheson DA: How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998, 2: 10-15. Mitcheson DA: How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998, 2: 10-15.
19.
go back to reference Dick J: The study of the determinants of non adherence to antituberculosis treatment: are we using appropriate research methodology?. Int J Tuberc Lung Dis. 1999, 3: 1049-PubMed Dick J: The study of the determinants of non adherence to antituberculosis treatment: are we using appropriate research methodology?. Int J Tuberc Lung Dis. 1999, 3: 1049-PubMed
Metadata
Title
Default from tuberculosis treatment in Tashkent, Uzbekistan; Who are these defaulters and why do they default?
Authors
Epco Hasker
Maksad Khodjikhanov
Shakhnoz Usarova
Umid Asamidinov
Umida Yuldashova
Marieke J van der Werf
Gulnoz Uzakova
Jaap Veen
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2008
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-8-97

Other articles of this Issue 1/2008

BMC Infectious Diseases 1/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.